New shot aims to shield city kids from dangerous asthma Flare-Ups
NCT ID NCT05347771
Summary
This study is testing if adding a medication called dupilumab to standard asthma treatment can help prevent severe asthma attacks in children and teenagers living in urban areas. About 240 participants, aged 6 to 17, who have frequent asthma flare-ups will receive either the new medication or a placebo injection alongside their usual care for one year. The main goal is to see if dupilumab reduces the number of times these kids need steroid treatments or hospital visits for their asthma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology
Chicago, Illinois, 60611, United States
-
Boston Children's Hospital: Department of Immunology
Boston, Massachusetts, 02215, United States
-
Children's Hospital Colorado: Allergy Program
Aurora, Colorado, 80045, United States
-
Children's National Medical Center: Children's Research Institute
Washington D.C., District of Columbia, 20010, United States
-
Cincinnati Children's Hospital Medical Center: Asthma Center
Cincinnati, Ohio, 45229, United States
-
Columbia University Medical Center: Division of Pediatric Pulmonology
New York, New York, 10032, United States
-
Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute
New York, New York, 10029, United States
-
Washington University at St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.